Oxford Asset Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Oxford Asset Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-8,975	Closed	-$484K	–	2060
2017 Q4	$484K	Sell	8,975 -252,428	-97%	-$13.8M	0.01%	1188
2017 Q3	$14.9M	Buy	261,403 +52,258	+25%	+$3.06M	0.29%	39
2017 Q2	$12.6M	Buy	209,145 +195,218	+1,402%	+$11.1M	0.25%	40
2017 Q1	$758K	Buy	+13,927	New	+$686K	0.02%	917

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Oxford Asset Management's BIVV Position: Q1 2018 in Review

Oxford Asset Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 8,975 shares — an estimated $484K sold.

Oxford Asset Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $14.9M in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Oxford Asset Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Oxford Asset Management sold 8,975 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $484K.
Oxford Asset Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Oxford Asset Management's Bioverativ Inc. Common Stock position peaked at $14.9M in Q3 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Oxford Asset Management's 13F filing for Q1 2018, filed 15 May 2018.